

Respiratory Syncytial Virus (RSV) Testing Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Respiratory Syncytial Virus (RSV) Testing market is projected to witness significant growth due to the increasing prevalence of respiratory infections. The market size is estimated to reach $800 million by 2025, with a CAGR of 7.5%. Factors such as technological advancements and rising awareness about early diagnosis are driving market growth.
◍ BD
◍ Princeton BioMeditech Corporation
◍ Roche
◍ Abbot (Alere)
◍ Analytik Jena
◍ Quidel
◍ Sekisui Diagnostics
◍ Meridian Bioscience
◍ Thermo Fisher Scientific
◍ BioMerieux
◍ Response Biomedical
◍ SA Scientific
◍ DiaSorin (Focus Diagnostics)
The competitive landscape of the Respiratory Syncytial Virus (RSV) Testing Market includes companies such as BD, Princeton BioMeditech Corporation, Roche, Abbott (Alere), Analytik Jena, Quidel, Sekisui Diagnostics, Meridian Bioscience, Thermo Fisher Scientific, BioMerieux, Response Biomedical, SA Scientific, and DiaSorin (Focus Diagnostics). These companies provide RSV testing solutions and contribute to the growth of the market by developing innovative products and expanding their global presence.
- Roche reported sales revenue of $61.8 billion in 2020.
- Abbott (Alere) reported sales revenue of $34.6 billion in 2020.
- Thermo Fisher Scientific reported sales revenue of $25.5 billion in 2020.
Request Sample Report
By Application
◍ Hospitals
◍ POCT
◍ Others
◍ Testing Services
◍ Testing Kits
◍ Others
Request Sample Report